Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Phase II Study of 177 Lu-DOTATATE for Progressive Metastatic Pheochromocytomas and Paragangliomas: Interim Analysis of Efficacy, Safety, and Biomarkers

Journal of Clinical Oncology(2025)10.1200/jco-25-00791Source: DataRank Database

Phase II Study of 177 Lu-DOTATATE for Progressive Metastatic Pheochromocytomas and Paragangliomas: Interim Analysis of Efficacy, Safety, and Biomarkers is a research paper published in Journal of Clinical Oncology (2025). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 18.52)OA: greenTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (20)

Jaydira Del Rivero ORCID,Jorge A. Carrasquillo ORCID,A. Jha ORCID,Joy Zou,Inna Shamis

Live enrichment

PubMed:40829092 PMC:PMC12367064 OpenAlex:https://openalex.org/W4413315817

Intramural NIH HHS

Grant: ZIA BC011789

FWCI

18.52

Citation Percentile

1.0%

Citation Trend

2025

2026

green

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12367064

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/12367064

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12367064

publisherhttps://ascopubs.org/doi/pdfdirect/10.1200/JCO-25-00791

journalhttps://doi.org/10.1200/jco-25-00791

Fields of Study

Adrenal and Paraganglionic TumorsNeuroblastoma Research and TreatmentsNeuroendocrine Tumor Research AdvancesMedicineHumansFemaleMaleMiddle AgedOrganometallic CompoundsOctreotidePheochromocytomaAdultParagangliomaAdrenal Gland NeoplasmsAgedBiomarkers, TumorRadiopharmaceuticalsProspective StudiesProgression-Free Survival

MeSH Terms

Progression-Free SurvivalAdrenal Gland NeoplasmsAdultAgedFemaleHumansMaleMiddle AgedOrganometallic CompoundsParagangliomaPheochromocytomaProspective StudiesBiomarkers, TumorOctreotideRadiopharmaceuticals

Keywords

MedicineInterim analysisInterimOncologyInternal medicineNuclear medicineClinical trial